Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$730M |
| 2 |
Robinhood
HOOD
|
+$449M |
| 3 |
SGFY
Signify Health, Inc.
SGFY
|
+$358M |
| 4 |
Coinbase
COIN
|
+$339M |
| 5 |
Ginkgo Bioworks
DNA
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.05B |
| 2 |
Sea Limited
SE
|
+$576M |
| 3 |
XYZ
Block Inc
XYZ
|
+$493M |
| 4 |
Shopify
SHOP
|
+$445M |
| 5 |
P
Everpure Inc
P
|
+$337M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.27% |
| 2 | Technology | 28.71% |
| 3 | Communication Services | 13.56% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Financials | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Twist Bioscience
TWST
$9.13B
| $422M | 1.01% |
3,946,409
-1,108,455
| -22% | -$127M |
|
|
27
Robinhood
HOOD
$97.2B
| $416M | 1% |
+9,876,801
| New | +$449M |
|
28
PagerDuty
PD
$950M
| $414M | 0.99% |
9,996,968
+1,403,361
| +16% | +$59.5M |
|
|
TSP
29
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $383M | 0.92% |
10,314,228
+3,841,493
| +59% | +$162M |
|
30
Trimble
TRMB
$14B
| $365M | 0.88% |
4,433,239
-825,154
| -16% | -$72.5M |
|
31
Veracyte
VCYT
$3.4B
| $324M | 0.78% |
6,980,201
+290,938
| +4% | +$12.7M |
|
|
SGFY
32
DELISTED
Signify Health, Inc.
SGFY
| $320M | 0.77% |
17,933,990
+13,917,369
| +346% | +$358M |
|
33
Vertex Pharmaceuticals
VRTX
$139B
| $310M | 0.74% |
1,709,751
-64,315
| -4% | -$12.6M |
|
|
34
Sea Limited
SE
$72B
| $304M | 0.73% |
953,280
-1,876,637
| -66% | -$576M |
|
35
Iovance Biotherapeutics
IOVA
$3.76B
| $287M | 0.69% |
11,649,837
-6,800,876
| -37% | -$160M |
|
36
Ionis Pharmaceuticals
IONS
$9.93B
| $285M | 0.69% |
8,511,384
-396,349
| -4% | -$14.9M |
|
|
TWOU
37
DELISTED
2U Inc
TWOU
| $282M | 0.68% |
280,409
-32,328
| -10% | -$37.9M |
|
|
38
Ginkgo Bioworks
DNA
$498M
| $269M | 0.65% |
+580,771
| New | +$283M |
|
39
Regeneron Pharmaceuticals
REGN
$85.9B
| $259M | 0.62% |
428,147
-284,901
| -40% | -$177M |
|
40
Editas Medicine
EDIT
$478M
| $259M | 0.62% |
6,297,359
-882,696
| -12% | -$48.4M |
|
41
Takeda Pharmaceutical
TAK
$58.1B
| $221M | 0.53% |
13,501,650
-1,991,347
| -13% | -$33.4M |
|
|
ACCD
42
DELISTED
Accolade Inc
ACCD
| $221M | 0.53% |
5,231,496
-185,510
| -3% | -$8.72M |
|
43
CareDx
CDNA
$2.51B
| $216M | 0.52% |
3,410,153
-1,153,957
| -25% | -$87.9M |
|
44
Kratos Defense & Security Solutions
KTOS
$10.7B
| $213M | 0.51% |
9,563,962
+1,218,325
| +15% | +$30.1M |
|
45
Veeva Systems
VEEV
$40.3B
| $212M | 0.51% |
736,180
-139,409
| -16% | -$44.2M |
|
46
PayPal
PYPL
$52.7B
| $198M | 0.48% |
762,007
-203,626
| -21% | -$57.8M |
|
47
Incyte
INCY
$25.9B
| $198M | 0.47% |
2,872,346
-76,621
| -3% | -$5.82M |
|
|
FIRY
48
Firy Inc
FIRY
$160M
| $185M | 0.44% |
941,805
-288,389
| -23% | -$74.6M |
|
49
Protolabs
PRLB
$1.9B
| $174M | 0.42% |
2,619,323
-411,307
| -14% | -$32.1M |
|
50
JD.com
JD
$39.7B
| $173M | 0.42% |
2,399,639
-3,875,078
| -62% | -$286M |
|
Similar funds
Cathie Wood's Q3 2021 Portfolio in Review
As of Q3 2021, Cathie Wood held 337 positions worth $41.6B, down 23% from $53.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Cathie Wood withdrew a net $4.54B in Q3 2021, closing 38 positions and reducing 174 holdings. Its most notable exit was Everpure Inc, an estimated $337M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Cathie Wood opened a new position in Robinhood worth $416M.
- Cathie Wood's largest Q3 2021 buy was Robinhood: 9,876,801 shares worth $416M.
- Cathie Wood added most to UiPath in Q3 2021, an estimated $730M increase.
- Cathie Wood's biggest Q3 2021 reduction was Tesla, cutting an estimated $1.05B.
- Cathie Wood fully exited Everpure Inc in Q3 2021, selling an estimated $337M.
- Cathie Wood's ten largest holdings make up 38% of its $41.6B portfolio in Q3 2021.
- Cathie Wood opened 52 new positions and closed 38 in Q3 2021.
- Cathie Wood's portfolio value fell 23% quarter-over-quarter to $41.6B.
Based on ARK Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.